ESTABLISHMENT LABS HOLDINGS INC. ESTA
Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0001688757 · Fiscal year ends 1231
Revenue
$211.08M
Fiscal year ended 2025-12-31Operating income
-$39.01M
Fiscal year ended 2025-12-31Free cash flow
-$56.94M
Fiscal year ended 2025-12-31ESTABLISHMENT LABS HOLDINGS INC. (ESTA) reported revenue of $211.08M and net income of -$51.06M for the fiscal year ended 2025-12-31. This page shows 9 annual periods of income statement, balance sheet and cash flow figures normalized from ESTABLISHMENT LABS HOLDINGS INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Income
ESTABLISHMENT LABS HOLDINGS INC. income by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|
| Revenue | $211.08M | $166.02M | $165.15M | $161.70M | $126.68M | $84.68M | $89.56M | $61.21M | $34.68M |
|---|
| Cost of revenue | $64.77M | $56.50M | $58.17M | $55.10M | $41.28M | $32.17M | $34.70M | $25.09M | $16.98M |
|---|
| Gross profit | $146.31M | $109.52M | $106.98M | $106.60M | $85.40M | $52.50M | $54.86M | $36.12M | $17.70M |
|---|
| Operating income | -$39.01M | -$49.99M | -$65.03M | -$39.66M | -$25.14M | -$27.92M | -$30.94M | -$23.86M | -$19.98M |
|---|
| Net income | -$51.06M | -$84.60M | -$78.50M | -$75.21M | -$41.14M | -$38.12M | -$38.15M | -$21.10M | -$34.90M |
|---|
| Research & development | $20.25M | $19.71M | $26.43M | $20.27M | $18.32M | $13.79M | $14.99M | $12.69M | $6.86M |
|---|
| Weighted-average diluted shares | shares 29.62M | shares 28.16M | shares 25.60M | shares 24.46M | shares 23.97M | shares 23.32M | shares 20.54M | —Unavailable | —Unavailable |
|---|
| Pretax income | -$58.02M | -$84.63M | -$78.58M | -$72.82M | -$39.71M | -$38.02M | -$37.51M | -$20.88M | -$34.79M |
|---|
| Income tax expense | -$6.96M | -$32.00K | -$81.00K | $2.38M | $1.43M | $104.00K | $640.00K | $215.00K | $105.00K |
|---|
| Diluted EPS | $-1.72 | $-3.00 | $-3.07 | $-3.08 | $-1.72 | $-1.63 | $-1.86 | —Unavailable | —Unavailable |
|---|
| Selling, general & administrative | $165.07M | $139.81M | $145.58M | $125.98M | $92.23M | $66.62M | $70.81M | $47.30M | $30.82M |
|---|
| General & administrative | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Selling & marketing | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Balance
ESTABLISHMENT LABS HOLDINGS INC. balance by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|
| Cash & equivalents | $75.57M | $90.35M | $40.04M | $66.36M | —Unavailable | —Unavailable | —Unavailable | $52.64M | $10.86M |
|---|
| Total assets | $357.17M | $346.83M | $268.64M | $211.06M | $139.53M | $156.39M | $116.53M | $116.57M | $57.10M |
|---|
| Current assets | $249.94M | $243.04M | $174.90M | $149.90M | $113.27M | $132.30M | $95.84M | $99.44M | $39.38M |
|---|
| Total liabilities | $333.62M | $293.74M | $250.25M | $219.25M | $88.79M | $81.43M | $76.92M | $47.09M | $62.11M |
|---|
| Current liabilities | $82.14M | $68.28M | $57.15M | $38.96M | $31.89M | $25.90M | $23.24M | $16.45M | $57.44M |
|---|
| Total equity incl. NCI | $23.55M | $53.10M | $18.40M | -$8.18M | $50.74M | $74.96M | $39.61M | $69.48M | -$5.01M |
|---|
| Temporary (mezzanine) equity | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Inventory | $85.61M | $78.77M | $79.47M | $36.58M | $28.41M | $23.21M | $28.66M | $24.84M | $13.17M |
|---|
| Accounts receivable | $77.50M | $65.00M | $46.92M | $35.42M | $24.44M | $19.13M | $22.77M | $17.65M | $13.11M |
|---|
| Goodwill | $1.21M | $1.21M | $465.00K | $465.00K | $465.00K | $465.00K | $465.00K | $465.00K | $465.00K |
|---|
| Long-term debt | $247.52M | $219.58M | $188.74M | $175.46M | $51.91M | $49.83M | $48.14M | —Unavailable | —Unavailable |
|---|
| Accounts payable | $43.11M | $44.76M | $41.62M | $20.03M | $14.48M | $9.72M | $10.37M | $6.24M | $9.13M |
|---|
Cash flow
ESTABLISHMENT LABS HOLDINGS INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|
| Operating cash flow | -$50.89M | -$58.52M | -$88.51M | -$52.17M | -$27.53M | -$12.51M | -$29.98M | -$33.88M | -$31.97M |
|---|
| Capital expenditures | $6.05M | $6.11M | $7.91M | $2.85M | $2.42M | $2.11M | $6.29M | $1.73M | $901.00K |
|---|
| Investing cash flow | -$7.03M | -$15.61M | -$24.55M | -$34.79M | -$7.16M | -$5.56M | -$7.77M | -$5.73M | -$845.00K |
|---|
| Financing cash flow | $40.43M | $125.90M | $86.23M | $100.26M | $4.05M | $64.67M | $22.79M | $81.53M | $42.99M |
|---|
| Net change in cash | -$14.78M | $50.31M | -$26.32M | $12.94M | -$31.11M | $46.87M | -$14.98M | $41.78M | $10.38M |
|---|
| Stock-based compensation | $11.42M | $14.40M | $14.36M | $13.36M | $10.41M | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Common dividends paid | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Common share repurchases | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | $0 | $4.51M |
|---|
| Depreciation & amortization | $6.20M | $4.70M | $2.80M | $2.50M | $2.50M | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Derived
ESTABLISHMENT LABS HOLDINGS INC. derived by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|
| Free cash flow | -$56.94M | -$64.63M | -$96.42M | -$55.02M | -$29.96M | -$14.62M | -$36.27M | -$35.62M | -$32.87M |
|---|
| Gross margin | 69.3% | 66.0% | 64.8% | 65.9% | 67.4% | 62.0% | 61.3% | 59.0% | 51.0% |
|---|
| Operating margin | -18.5% | -30.1% | -39.4% | -24.5% | -19.8% | -33.0% | -34.5% | -39.0% | -57.6% |
|---|
| FCF margin | -27.0% | -38.9% | -58.4% | -34.0% | -23.6% | -17.3% | -40.5% | -58.2% | -94.8% |
|---|
| SBC / revenue | 5.4% | 8.7% | 8.7% | 8.3% | 8.2% | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Current ratio | 3.04x | 3.56x | 3.06x | 3.85x | 3.55x | 5.11x | 4.12x | 6.05x | 0.69x |
|---|
| Revenue YoY growth | 27.1% | 0.5% | 2.1% | 27.6% | 49.6% | -5.5% | 46.3% | 76.5% | —Unavailable |
|---|
| Net margin | -24.2% | -51.0% | -47.5% | -46.5% | -32.5% | -45.0% | -42.6% | -34.5% | -100.6% |
|---|
| R&D / revenue | 9.6% | 11.9% | 16.0% | 12.5% | 14.5% | 16.3% | 16.7% | 20.7% | 19.8% |
|---|
| CapEx / revenue | 2.9% | 3.7% | 4.8% | 1.8% | 1.9% | 2.5% | 7.0% | 2.8% | 2.6% |
|---|
| Long-term debt / equity | 10.51x | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Effective tax rate | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ESTA in the interactive workspace to inspect any figure back to its filing.
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.